DE60206736D1 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinon-derivative als protein-kinase inhibitoren - Google Patents

3-(4-amidopyrrol-2-ylmethylidene)-2-indolinon-derivative als protein-kinase inhibitoren

Info

Publication number
DE60206736D1
DE60206736D1 DE60206736T DE60206736T DE60206736D1 DE 60206736 D1 DE60206736 D1 DE 60206736D1 DE 60206736 T DE60206736 T DE 60206736T DE 60206736 T DE60206736 T DE 60206736T DE 60206736 D1 DE60206736 D1 DE 60206736D1
Authority
DE
Germany
Prior art keywords
amidopyrrol
indolinon
ylmethylidene
inhibitoren
kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60206736T
Other languages
English (en)
Other versions
DE60206736T2 (de
Inventor
Huiping Guan
Congxin Liang
Li Sun
Cho Tang
Chen Wei
A Mauragis
Tomas Vojkovsky
Qingwu Jin
Matthew Herrinton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sugen LLC
Pharmacia and Upjohn Co LLC
Original Assignee
Sugen LLC
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen LLC, Pharmacia and Upjohn Co LLC filed Critical Sugen LLC
Application granted granted Critical
Publication of DE60206736D1 publication Critical patent/DE60206736D1/de
Publication of DE60206736T2 publication Critical patent/DE60206736T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
DE60206736T 2001-02-15 2002-02-15 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinon-derivative als protein-kinase inhibitoren Expired - Lifetime DE60206736T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26868301P 2001-02-15 2001-02-15
US268683P 2001-02-15
US31236101P 2001-08-15 2001-08-15
US312361P 2001-08-15
PCT/US2002/004407 WO2002066463A1 (en) 2001-02-15 2002-02-15 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors

Publications (2)

Publication Number Publication Date
DE60206736D1 true DE60206736D1 (en) 2006-03-02
DE60206736T2 DE60206736T2 (de) 2006-08-03

Family

ID=26953263

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60206736T Expired - Lifetime DE60206736T2 (de) 2001-02-15 2002-02-15 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinon-derivative als protein-kinase inhibitoren

Country Status (41)

Country Link
US (4) US6653308B2 (de)
EP (1) EP1370554B1 (de)
JP (1) JP3677501B2 (de)
KR (1) KR100884858B1 (de)
CN (1) CN100338059C (de)
AP (1) AP1718A (de)
AR (1) AR042586A1 (de)
AT (1) ATE307128T1 (de)
AU (1) AU2002247133B2 (de)
BG (1) BG108098A (de)
BR (1) BR0207494A (de)
CA (1) CA2438314C (de)
CR (1) CR7056A (de)
CZ (1) CZ20032414A3 (de)
DE (1) DE60206736T2 (de)
DK (1) DK1370554T3 (de)
EA (1) EA007186B1 (de)
EE (1) EE200300385A (de)
ES (1) ES2251580T3 (de)
GE (1) GEP20053600B (de)
HK (1) HK1059621A1 (de)
HR (1) HRP20030657B1 (de)
HU (1) HUP0303146A3 (de)
IL (2) IL157418A0 (de)
IS (1) IS2411B (de)
MA (1) MA26997A1 (de)
MX (1) MXPA03007367A (de)
MY (1) MY126235A (de)
NO (1) NO326604B1 (de)
NZ (1) NZ527572A (de)
OA (1) OA12834A (de)
PE (1) PE20021006A1 (de)
PL (1) PL364176A1 (de)
RS (1) RS51026B (de)
SI (1) SI1370554T1 (de)
SK (1) SK11332003A3 (de)
TN (1) TNSN03055A1 (de)
TW (1) TWI324155B (de)
UA (1) UA75635C2 (de)
WO (1) WO2002066463A1 (de)
ZA (2) ZA200306335B (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861442B1 (en) * 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
TWI259081B (en) * 2001-10-26 2006-08-01 Sugen Inc Treatment of acute myeloid leukemia with indolinone compounds
RU2299209C2 (ru) 2002-02-15 2007-05-20 Фармация Энд Апджон Компани Способ получения производных индолинона
AU2003233576A1 (en) * 2002-05-17 2003-12-02 Sugen, Inc. Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
AR042042A1 (es) * 2002-11-15 2005-06-08 Sugen Inc Administracion combinada de una indolinona con un agente quimioterapeutico para trastornos de proliferacion celular
US20040209937A1 (en) * 2003-02-24 2004-10-21 Sugen, Inc. Treatment of excessive osteolysis with indolinone compounds
DE10334582A1 (de) * 2003-07-28 2005-02-24 Basf Ag Verfahren zur Herstellung von Maleinsäureanhydrid
AU2004277464B2 (en) * 2003-10-02 2010-07-08 Pharmacia & Upjohn Company Llc Salts and polymorphs of a pyrrole-substituted indolinone compound
CN1898205A (zh) 2003-10-24 2007-01-17 舍林股份公司 吲哚满酮衍生物及其在治疗疾病状态如癌症中的用途
WO2005053614A2 (en) * 2003-11-26 2005-06-16 The Scripps Research Institute Advanced indolinone based protein kinase inhibitors
CN102127058A (zh) 2004-05-14 2011-07-20 辉瑞产品有限公司 治疗异常细胞生长的嘧啶衍生物
US20060009510A1 (en) * 2004-07-09 2006-01-12 Pharmacia & Upjohn Company Llc Method of synthesizing indolinone compounds
PT1848414E (pt) * 2005-02-03 2011-05-25 Gen Hospital Corp M?todo para tratamento de cancro resistente a gefitinib
US20090074787A1 (en) * 2005-03-23 2009-03-19 Pfizer, Inc., Pfizer Products, Inc. Anti-CTLA4 Antibody and Indolinone Combination Therapy for Treatment of Cancer
EP2444421A1 (de) 2005-04-26 2012-04-25 Pfizer Inc. P-Cadherin-Antikörper
US20100267719A1 (en) * 2005-05-26 2010-10-21 The Scripps Research Institute Enhanced Indolinone Based Protein Kinase Inhibitors
TWI541253B (zh) 2005-09-07 2016-07-11 艾默根佛蒙特有限公司 針對類活化素受體激酶-１之人類單株抗體
AU2006293620A1 (en) * 2005-09-20 2007-03-29 Pfizer Products Inc. Dosage forms and methods of treatment using a tyrosine kinase inhibitor
CA2621809A1 (en) * 2005-09-22 2007-04-05 The Scripps Research Institute Alkoxy indolinone based protein kinase inhibitors
CA2635360A1 (en) * 2005-12-29 2007-07-19 The Scripps Research Institute Amino acid derivatives of indolinone based protein kinase inhibitors
JP4383525B2 (ja) 2006-05-09 2009-12-16 ファイザー・プロダクツ・インク シクロアルキルアミノ酸誘導体およびその医薬組成物
US20070282318A1 (en) * 2006-05-16 2007-12-06 Spooner Gregory J Subcutaneous thermolipolysis using radiofrequency energy
AU2007296744A1 (en) * 2006-09-11 2008-03-20 Curis, Inc. Multi-functional small molecules as anti-proliferative agents
EP2061758A4 (de) 2006-09-11 2011-11-30 Curis Inc Eine zinkbindende gruppe enthaltende substituierte 2-indolinone als ptk-inhibitoren
PL2079727T3 (pl) 2006-09-15 2016-08-31 Xcovery Inc Inhibitory kinazy
WO2008127707A1 (en) * 2007-04-13 2008-10-23 Dana Farber Cancer Institute, Inc. Receptor tyrosine kinase profiling
WO2008145398A1 (en) * 2007-06-01 2008-12-04 Pfizer Italia S.R.L. 4-arylpyrrole substituted 2-indoline derivatives active as protein kinase inhibitors
WO2009014941A1 (en) * 2007-07-24 2009-01-29 Shenzen Chipscreen Bioscience, Ltd. 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
CL2008002793A1 (es) * 2007-09-20 2009-09-04 Cgi Pharmaceuticals Inc Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras
US20100256392A1 (en) * 2007-11-21 2010-10-07 Teva Pharmaceutical Industries Ltd. Polymorphs of sunitinib base and processes for preparation thereof
EP2274303B1 (de) * 2008-03-31 2012-08-29 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung von sunitinib und salzen davon
US8158656B2 (en) * 2008-05-16 2012-04-17 Shenzhen Chipscreen Biosciences Ltd. 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
CN102066362B (zh) 2008-05-23 2014-07-30 上海医药工业研究院 二氢吲哚酮衍生物
AU2009267048A1 (en) * 2008-06-30 2010-01-07 Cylene Pharmaceuticals, Inc. Oxindole compounds
US20100029491A1 (en) * 2008-07-11 2010-02-04 Maike Schmidt Methods and compositions for diagnostic use for tumor treatment
WO2010011834A2 (en) 2008-07-24 2010-01-28 Teva Pharmaceutical Industries Ltd. Sunitinib and salts thereof and their polymorphs
US8211901B2 (en) 2009-05-22 2012-07-03 Shenzhen Chipscreen Biosciences Ltd. Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
CN101906076B (zh) 2009-06-04 2013-03-13 深圳微芯生物科技有限责任公司 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
US20110076271A1 (en) 2009-07-13 2011-03-31 Genentech, Inc. Diagnostic methods and compositions for treatment of cancer
FR2948940B1 (fr) * 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2013503846A (ja) 2009-09-01 2013-02-04 ファイザー・インク ベンズイミダゾール誘導体
CN102597776A (zh) 2009-09-11 2012-07-18 霍夫曼-拉罗奇有限公司 鉴定响应抗癌剂的可能性升高的患者的方法
MX2012002909A (es) 2009-09-17 2012-04-19 Hoffmann La Roche Metodos y composiciones para su uso en diagnostico de pacientes con cancer.
WO2011073521A1 (en) 2009-12-15 2011-06-23 Petri Salven Methods for enriching adult-derived endothelial progenitor cells and uses thereof
EP2550263A4 (de) * 2010-03-23 2013-07-24 Univ Johns Hopkins Zusammensetzungen und verfahren zur behandlung neurodegenerativer erkrankungen
WO2011153224A2 (en) 2010-06-02 2011-12-08 Genentech, Inc. Diagnostic methods and compositions for treatment of cancer
JP2013534307A (ja) 2010-07-19 2013-09-02 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 抗癌治療への応答可能性の増大した患者を同定する方法
WO2012010549A1 (en) 2010-07-19 2012-01-26 F. Hoffmann-La Roche Ag Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
AU2011280969A1 (en) 2010-07-23 2013-02-07 Trustees Of Boston University Anti-Despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
WO2012042421A1 (en) 2010-09-29 2012-04-05 Pfizer Inc. Method of treating abnormal cell growth
WO2012052948A1 (en) 2010-10-20 2012-04-26 Pfizer Inc. Pyridine- 2- derivatives as smoothened receptor modulators
WO2012139019A2 (en) * 2011-04-08 2012-10-11 Beta Pharma, Inc. New indolinone protein kinase inhibitors
US20140107151A1 (en) * 2011-05-17 2014-04-17 Principia Biophama Inc. Tyrosine kinase inhibitors
MX2014003501A (es) 2011-09-22 2014-07-22 Pfizer Derivados de pirrolopirimidina y purina.
DK3181567T3 (da) 2012-09-10 2019-06-11 Principia Biopharma Inc Pyrazolopyrimidinforbindelser som kinasehæmmere
CN103274986A (zh) * 2013-06-20 2013-09-04 湖南欧亚生物有限公司 一种舒尼替尼中间体的合成和精制方法
FR3008411B1 (fr) * 2013-07-12 2015-07-03 Servier Lab Nouveau sel de la 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, sa preparation, et les formulations qui le contiennent
UA115388C2 (uk) 2013-11-21 2017-10-25 Пфайзер Інк. 2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань
SG11201606858RA (en) 2014-02-21 2016-09-29 Principia Biopharma Inc Salts and solid form of a btk inhibitor
WO2015155624A1 (en) 2014-04-10 2015-10-15 Pfizer Inc. Dihydropyrrolopyrimidine derivatives
AP2016009530A0 (en) 2014-04-30 2016-10-31 Pfizer Cycloalkyl-linked diheterocycle derivatives
WO2016001789A1 (en) 2014-06-30 2016-01-07 Pfizer Inc. Pyrimidine derivatives as pi3k inhibitors for use in the treatment of cancer
ES2843323T3 (es) 2014-12-18 2021-07-16 Principia Biopharma Inc Tratamiento de pénfigo
CN104592143B (zh) * 2015-01-23 2017-04-05 四川大学 一种噁唑烷酮类化合物的制备方法
EP3313839A1 (de) 2015-06-24 2018-05-02 Principia Biopharma Inc. Tyrosin-kinase-inhibitoren
WO2017009751A1 (en) 2015-07-15 2017-01-19 Pfizer Inc. Pyrimidine derivatives
CA2995675C (en) 2015-08-31 2023-12-12 Dong-A Socio Holdings Co., Ltd. Heteroaryl compounds and their use as therapeutic drugs
CN106928114B (zh) * 2015-12-31 2020-07-28 韶远科技（上海)有限公司 含有脲基的环状手性氨基类化合物及其可放大工艺和用途
CA3028169A1 (en) 2016-06-29 2018-01-04 Principia Biopharma Inc. Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
AU2019352075B2 (en) * 2018-10-05 2022-07-21 Ichnos Sciences S.A. Indolinone compounds for use as MAP4K1 inhibitors
WO2023081923A1 (en) 2021-11-08 2023-05-11 Frequency Therapeutics, Inc. Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL104796C (de) 1957-08-19
DE878539C (de) 1939-08-17 1953-06-05 Hoechst Ag Verfahren zur Herstellung von Methinfarbstoffen
US2622960A (en) * 1948-03-16 1952-12-23 A P W Products Company Inc Glyoxal treatment of absorbent paper to improve wet strength
BE507136A (de) 1950-11-18
BE553661A (de) 1955-12-23
NL96047C (de) 1956-06-08
NL251055A (de) 1959-04-29
FR1398224A (fr) 1964-05-06 1965-05-07 Ici Ltd Procédé de teinture de matières textiles de polyacrylonitrile
US3308134A (en) 1965-10-22 1967-03-07 Mcneilab Inc Spiro(indan-2, 3'-indoline)-1, 2'-diones
US3551571A (en) 1967-05-19 1970-12-29 Endo Lab Methods for reducing pain,reducing fever and alleviating inflammatory syndromes with heteroaromatic pyrrol-3-yl ketones
US3564016A (en) 1968-03-07 1971-02-16 Endo Lab Method of decarbonylation
US4070366A (en) 1968-06-12 1978-01-24 Canadian Patents & Development Limited Alkylation process
FR1599772A (de) 1968-09-17 1970-07-20
US3922163A (en) 1970-01-30 1975-11-25 Upjohn Co Organic compounds and process
US3715364A (en) 1970-12-28 1973-02-06 Merck & Co Inc Nitroimidazole carboxamides
DE2159360A1 (de) 1971-11-30 1973-06-14 Bayer Ag Nitrofuranderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2159361A1 (de) 1971-11-30 1973-06-14 Bayer Ag Nitrofuranderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2159362A1 (de) 1971-11-30 1973-06-14 Bayer Ag Nitrofuranderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2159363A1 (de) 1971-11-30 1973-06-14 Bayer Ag Antimikrobielle mittel
GB1384599A (en) 1972-05-04 1975-02-19 Colgate Palmolive Co Coloured detergent compositions
JPS4918256A (de) * 1972-06-09 1974-02-18
US3880871A (en) 1973-09-27 1975-04-29 Squibb & Sons Inc Isothiocyanophenyl substituted imidazoles
US4002643A (en) 1975-06-27 1977-01-11 Mcneil Laboratories, Inc. Preparation of β-acyl pyrroles
US4002749A (en) 1975-08-12 1977-01-11 E. R. Squibb & Sons, Inc. Substituted indolinones
US4053613A (en) 1975-09-17 1977-10-11 E. R. Squibb & Sons, Inc. 1,3,thiazolinyl and 1,3 thiazinyl substituted indolinones
GR73560B (de) 1979-02-24 1984-03-15 Pfizer
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4343923A (en) 1980-08-07 1982-08-10 Armstrong World Industries, Inc. Process for reducing the acid dye uptake of polyamide textile materials with N-acylimidazole compound
CH646956A5 (de) 1981-12-15 1984-12-28 Ciba Geigy Ag Imidazolide.
EP0095285A1 (de) 1982-05-21 1983-11-30 Sumitomo Chemical Company, Limited N-Acylimidazole, Verfahren zu deren Herstellung und deren Anwendung
DE3310891A1 (de) 1983-03-25 1984-09-27 Boehringer Mannheim Gmbh, 6800 Mannheim Neue indolinon-(2)-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte
US4489089A (en) 1983-04-06 1984-12-18 American Cyanamid Company Substituted N-[ω-(1H-imidazol-1-yl)alkyl]-amides
DE3480392D1 (en) 1983-04-29 1989-12-14 Ciba Geigy Ag Imidazolides and their use as curing agents for polyepoxides
DE3415138A1 (de) 1984-04-21 1985-10-31 Basf Ag, 6700 Ludwigshafen N-(azolylcarbamoyl)-hydroxylamine und diese enthaltende fungizide
DE3426419A1 (de) 1984-07-18 1986-01-23 Boehringer Mannheim Gmbh, 6800 Mannheim Neue oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte
US4560700A (en) 1985-02-08 1985-12-24 Merrell Dow Pharmaceuticals Inc. Pyrrole-3-carboxylate cardiotonic agents
JPH078851B2 (ja) 1985-07-29 1995-02-01 鐘淵化学工業株式会社 ３−フエニルチオメチルスチレン誘導体
US4966849A (en) 1985-09-20 1990-10-30 President And Fellows Of Harvard College CDNA and genes for human angiogenin (angiogenesis factor) and methods of expression
WO1993012786A1 (en) 1986-07-10 1993-07-08 Howard Harry R Jr Indolinone derivatives
US4853404A (en) 1986-10-13 1989-08-01 Tanabe Seiyaku Co., Ltd. Phenoxyacetic acid derivatives composition and use
JP2539504B2 (ja) 1987-03-11 1996-10-02 鐘淵化学工業株式会社 ヒドロキシスチレン誘導体
US5089516A (en) 1987-03-11 1992-02-18 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha 1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting activity
US5202341A (en) 1987-03-11 1993-04-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Hydroxystyrene compounds having tyrosine kinase inhibiting activity
US5043348A (en) 1987-04-24 1991-08-27 Cassella Aktiengesellschaft Pyrrolealdehydes, their preparation and their use
US5217999A (en) 1987-12-24 1993-06-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Styryl compounds which inhibit EGF receptor protein tyrosine kinase
DE3808071A1 (de) 1988-03-11 1989-09-21 Basf Ag Verfahren zur herstellung von acylierten imidazolen
US4868304A (en) 1988-05-27 1989-09-19 Iowa State University Research Foundation, Inc. Synthesis of nitrogen heterocycles
JPH06104658B2 (ja) 1988-06-23 1994-12-21 三菱化成株式会社 ピロールカルボン酸誘導体
CA1339784C (en) 1988-06-23 1998-03-31 Shinya Inoue Pyrrolecarboxylic acid derivatives
DE3824658A1 (de) 1988-07-15 1990-01-18 Schering Ag N-hetaryl-imidazolderivate
GB8816944D0 (en) 1988-07-15 1988-08-17 Sobio Lab Compounds
US5084280A (en) 1988-12-15 1992-01-28 Chapman Chemical Company Wood preservation composition and method
DE3902439A1 (de) 1989-01-27 1990-08-02 Basf Ag Pflanzenschuetzende mittel auf basis von 1-aryl- bzw. 1-hetarylimidazolcarbonsaeureestern
US5047554A (en) 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
ES2110965T3 (es) 1989-07-25 1998-03-01 Taiho Pharmaceutical Co Ltd Derivado de oxoindol.
US5258357A (en) 1989-10-07 1993-11-02 Basf Aktiengesellschaft Carboxamides, their preparation and their use as herbicides
CA2032421A1 (en) 1989-12-20 1991-06-21 Mitsubishi Chemical Corporation Pyrrolealdehyde derivative
GB9004483D0 (en) 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
CA2012634A1 (en) 1990-03-20 1991-09-20 Hassan Salari Tyrphostins for treatment of allergic, inflammatory and cardiovascular diseases
US5302606A (en) 1990-04-16 1994-04-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
US5196446A (en) 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
CH680293A5 (de) * 1990-06-26 1992-07-31 Lonza Ag
IT1247509B (it) 1991-04-19 1994-12-17 Univ Cagliari Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
US5409930A (en) 1991-05-10 1995-04-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5480883A (en) 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
GB9115160D0 (en) 1991-07-12 1991-08-28 Erba Carlo Spa Methylen-oxindole derivatives and process for their preparation
US5124347A (en) 1991-07-31 1992-06-23 Warner-Lambert Co. 3-5-ditertiarybutylphenyl-4-hydroxymethylidene derivatives of 1,3-dihydro-2H-indole-2-ones as antiinflammatory agents
CZ290470B6 (cs) 1991-10-18 2002-07-17 Monsanto Technology Llc 5 či 6 členné aromáty jako fungicidy pro kontrolu stéblolamu rostlin, způsob kontroly a fungicidní směs k provedení tohoto způsobu
US5322950A (en) 1991-12-05 1994-06-21 Warner-Lambert Company Imidazole with angiotensin II antagonist properties
US5389661A (en) 1991-12-05 1995-02-14 Warner-Lambert Company Imidazole and 1,2,4-triazole derivatives with angiotensin II antagonist properties
GB9300059D0 (en) 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
FR2689397A1 (fr) 1992-04-01 1993-10-08 Adir Utilisation des dérivés de la 3-(3,5-Ditert-Butyl-4-Hydroxybenzylidenyl) Indoline-2-one pour l'obtention de médicaments.
DE4211531A1 (de) 1992-04-06 1993-10-07 Cassella Ag Verfahren zur Herstellung von Pyrrolderivaten
FR2694004B1 (fr) 1992-07-21 1994-08-26 Adir Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
US5565324A (en) 1992-10-01 1996-10-15 The Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
US5330992A (en) 1992-10-23 1994-07-19 Sterling Winthrop Inc. 1-cyclopropyl-4-pyridyl-quinolinones
GB9226855D0 (en) 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation
JP3507124B2 (ja) 1993-05-26 2004-03-15 塩野義製薬株式会社 ベンジリデン誘導体の製造法
EP0632102B1 (de) 1993-06-28 1997-04-02 Bayer Ag Massefärben von Kunststoffen
US5332736A (en) 1993-11-01 1994-07-26 Ortho Pharmaceutical Corporation Anti-convulsant aroyl aminoacylpyrroles
US5610173A (en) 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
GB9507298D0 (en) 1995-04-07 1995-05-31 Pharmacia Spa Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors
US5880141A (en) 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
US5786488A (en) 1996-11-13 1998-07-28 Sugen, Inc. Synthetic methods for the preparation of indolyquinones
JP3246712B2 (ja) 1995-11-15 2002-01-15 株式会社トクヤマ エテニルアミド化合物の製造方法
DE19602525A1 (de) * 1996-01-25 1997-08-07 Starck H C Gmbh Co Kg Sphärische Keramikformkörper, Verfahren zu ihrer Herstellung sowie deren Verwendung
EP0788890A1 (de) 1996-02-06 1997-08-13 Agfa-Gevaert N.V. Farbstoffe und Farbstoffdonorelemente zur thermischen Farbstoffübertragungsaufzeichnung
CA2206201A1 (en) 1996-05-29 1997-11-29 Yoshiaki Isobe Pyrazole derivatives and their pharmaceutical use
WO1998005637A1 (de) 1996-08-01 1998-02-12 Merckle Gmbh Acylpyrroldicarbonsäuren und acylindoldicarbonsäuren sowie ihre derivate als hemmstoffe der cytosolischen phospholipase a¿2?
US6133305A (en) 1997-09-26 2000-10-17 Sugen, Inc. 3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
SK287132B6 (sk) 1998-05-29 2009-12-07 Sugen, Inc. Farmaceutická kompozícia obsahujúca pyrolom substituovaný 2-indolinón, súprava obsahujúca uvedenú kompozíciu a použitie pyrolom substituovaného 2-indolinónu
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6395736B1 (en) 1998-12-14 2002-05-28 Cellegy Pharmaceuticals, Inc. Compositions and methods for the treatment of anorectal disorders
CA2354852C (en) * 1998-12-17 2008-09-23 F. Hoffmann-La Roche Ag 4,5-azolo-oxindoles
ATE234830T1 (de) 1998-12-17 2003-04-15 Hoffmann La Roche 4-alkenyl (und alkinyl)oxoindole als inhibitoren cyclinabhängiger kinasen, insbesondere cdk2
US6284894B1 (en) 1998-12-18 2001-09-04 Nycomed Imaging As Preparation of allylic aromatic compounds
BRPI0108394B8 (pt) * 2000-02-15 2021-05-25 Upjohn Co inibidores de proteína de quinase de 2-indolinona de pirrol substituído, seus sais e composições farmacêuticas compreendendo os mesmos
TWI270545B (en) * 2000-05-24 2007-01-11 Sugen Inc Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
RU2299209C2 (ru) * 2002-02-15 2007-05-20 Фармация Энд Апджон Компани Способ получения производных индолинона

Also Published As

Publication number Publication date
EE200300385A (et) 2004-02-16
JP2004522776A (ja) 2004-07-29
WO2002066463A1 (en) 2002-08-29
EA007186B1 (ru) 2006-08-25
MXPA03007367A (es) 2005-07-25
DE60206736T2 (de) 2006-08-03
US20030092917A1 (en) 2003-05-15
MY126235A (en) 2006-09-29
EP1370554A1 (de) 2003-12-17
IS2411B (is) 2008-10-15
GEP20053600B (en) 2005-08-10
BR0207494A (pt) 2004-04-27
DK1370554T3 (da) 2006-02-06
JP3677501B2 (ja) 2005-08-03
ES2251580T3 (es) 2006-05-01
NO20033608D0 (no) 2003-08-14
SI1370554T1 (sl) 2006-04-30
AR042586A1 (es) 2005-06-29
OA12834A (en) 2006-09-15
IL157418A (en) 2011-03-31
AP2003002836A0 (en) 2003-09-30
CA2438314C (en) 2012-08-07
UA75635C2 (en) 2006-05-15
AP1718A (en) 2007-01-30
PE20021006A1 (es) 2002-11-08
US7582756B2 (en) 2009-09-01
TWI324155B (en) 2010-05-01
EP1370554B1 (de) 2005-10-19
US7256189B2 (en) 2007-08-14
CZ20032414A3 (cs) 2004-04-14
HK1059621A1 (en) 2004-07-09
YU71703A (sh) 2006-05-25
KR100884858B1 (ko) 2009-02-23
CN1529704A (zh) 2004-09-15
ATE307128T1 (de) 2005-11-15
HRP20030657A2 (xx) 2005-10-31
US20070027149A1 (en) 2007-02-01
IS6913A (is) 2003-08-14
HUP0303146A2 (hu) 2003-12-29
KR20030078921A (ko) 2003-10-08
RS51026B (sr) 2010-10-31
US20040102510A1 (en) 2004-05-27
CR7056A (es) 2004-02-02
ZA200405615B (en) 2005-06-27
CA2438314A1 (en) 2002-08-29
NO326604B1 (no) 2009-01-19
TNSN03055A1 (en) 2005-12-23
AU2002247133B2 (en) 2007-08-30
MA26997A1 (fr) 2004-12-20
US7179910B2 (en) 2007-02-20
CN100338059C (zh) 2007-09-19
BG108098A (bg) 2005-12-30
US20080045709A1 (en) 2008-02-21
IL157418A0 (en) 2004-03-28
NZ527572A (en) 2005-07-29
US6653308B2 (en) 2003-11-25
NO20033608L (no) 2003-10-14
HUP0303146A3 (en) 2007-08-28
ZA200306335B (en) 2005-01-26
HRP20030657B1 (en) 2006-10-31
PL364176A1 (en) 2004-12-13
EA200300793A1 (ru) 2004-04-29
SK11332003A3 (sk) 2004-04-06

Similar Documents

Publication Publication Date Title
DE60206736D1 (en) 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinon-derivative als protein-kinase inhibitoren
SI1671949T1 (sl) Substituirani pridinilamini
PL368909A1 (en) C-5 modified indazolylpyrrolotriazines
DE60210581D1 (en) Substituierte carbostyrilderivate als 5-ht1a-subtyp agonisten
PL362643A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
GB2396631B (en) Hinge mechanism
PT1406858E (pt) 4-aminociclo-hexanóis substituídos
IL160539A0 (en) Anti-influenzal agents
HU0400176V0 (en) Improved gasketseal
GB0122026D0 (en) Insulitis
AU2002313943A8 (en) Electromobile
GB0105120D0 (en) Mechanism
PL364601A1 (en) Substituted benzo-nitro-heterocycles
PL367864A1 (en) Novel combination
DE60133138D1 (en) (-)-olivil als antioxidationsmittel
GB0100929D0 (en) Control agents
TW463637U (en) Improved massaging mechanism
AU2001100134A4 (en) Enviro-trap
GB0120430D0 (en) Control agents
GB0115792D0 (en) Control Agents
GB0119130D0 (en) Steelmaking
GB0124171D0 (en) None available at present
GB0123481D0 (en) Improved fancopter
TW505173U (en) Improved doorstopper
GB0126462D0 (en) Improved gyrocopter

Legal Events

Date Code Title Description
8364 No opposition during term of opposition